SARS_CoV_2 mutation literature information.


  Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variants.
 PMID: 34848718       2021       Nature communications
Introduction: In this regard, some mutations in SARS-CoV-2 are responsible for large conformational changes that may enhance infection, such as those located in the distal region of the spike protein and near the fusion region as the well-known D614G.


  Rapid Identification of SARS-CoV-2 Variants of Concern Using a Portable peakPCR Platform.
 PMID: 34852455       2021       Analytical chemistry
Introduction: For example, the D614G variant has been shown to increase the viral load of infected patients and has replaced the original variant since June 2020 around the globe.


  Niclosamide shows strong antiviral activity in a human airway model of SARS-CoV-2 infection and a conserved potency against the Alpha (B.1.1.7), Beta (B.1.351) and Delta variant (B.1.617.2).
 PMID: 34855904       2021       PloS one
Abstract: Furthermore, niclosamide remains its potency against the D614G, Alpha (B.1.1.7), Beta (B.1.351), and Delta (B.1.617.2) variants.
Method: Briefly, human bronchial epithelial cells were apically infected with the European D614G strain of SARS-CoV-2 (BavPat1 D614G) at a multiplicity of infection (MOI) of 0.1 and cult
Result: Importantly, niclosamide also blocked the replication of the European BavPat D614G, B.1.1.7, B.1.351 and B.1.617.2 variant with an IC50 of 0.06 muM, 0.08 muM, 0.07 muM, and 0.08 muM respectively (Fig 2).


  Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern.
 PMID: 34856802       2021       Journal of chemical theory and computation
Result: Although our results are accordant with recently published studies, the reason why Kappa/Delta and Epsilon behaviors are distinctive remained to be further studied, and it might stem from the limitation in our model, as we only employed the L452R mutation in RBD for the Epsilon variant without a D614G mutation.


  Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.
 PMID: 34858404       2021       Frontiers in immunology
Result: In order to further corroborate whether these antibodies were also able to neutralize viral infection in a cell culture, we performed cVNT for lineage B SARS-CoV2 (D614G) and the Alpha, Gamma, and Delta variants.
Result: The GMT values obtained by cVNT for D614G strain and the Alpha, Gamma, and Delta variants were 74.8 (95% CI 59.8-93.6), 32.1(95% CI 20.1-51.1), 15.8 (95% CI 9.5-26.2) and 7.9 (95% CI 5.2-12), respectively.
Result: The results obtained showed that, as compared to the D614G strain, there was a 2.33-fold decrease in neutralizing antibodies against the Alpha variant, a 4.73-fold reduction against the Gamma variant and a 9.46-fold reduction against the Delta variant ( Figure 2A ).

Browser Board

 Co-occurred Entities




   Filtrator